EcoDrugPlus

Ensembl ID : ENSECRG00000017216
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSECRG00000009297
Gene Symbol: -
Cross references: -
147 Possible Orthologues:

Ensembl ID : ENSECRG00000022212
Gene Symbol: -
Cross references: -
986 Possible Orthologues:

Ensembl ID : ENSECRG00000022217
Gene Symbol: -
Cross references: -
269 Possible Orthologues:

Ensembl ID : ENSECRG00000022592
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSECRG00000022603
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSECRG00000022617
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSECRG00000022629
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSECRG00000008308
Gene Symbol: -
Cross references: -
282 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).